CADM2 and Alzheimer disease: By integrating cis-eQTL data from Braineac and GTEx, we identified two shared risk genes, namely MAPT and CADM2. MAPT encodes the microtubule-associated protein tau, a protein central to Alzheimer’s disease neuropathology.